Serological assays for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), March 2020.
Perera RA, Mok CK, Tsang OT, Lv H, Ko RL, Wu NC, Yuan M, Leung WS, Chan JM, Chik TS, Choi CY, Leung K, Chan KH, Chan KC, Li KC, Wu JT, Wilson IA, Monto AS, Poon LL, Peiris M. · 2020
Read Serological assays for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), March 2020. by Perera RA, Mok CK, Tsang OT, Lv H, Ko RL, Wu NC, Yuan M, Leung WS, Chan JM, Chik TS, Choi CY, Leung K, Chan KH, Chan KC, Li KC, Wu JT, Wilson IA, Monto AS, Poon LL, Peiris M. (2020) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7189648.txt.
Description
Perera and co-authors develop blood tests for antibodies to SARS-CoV-2. Their report appeared in Eurosurveillance in March 2020. Counting past infections helps estimate how severe the disease is overall. It also shows how close a population is to herd immunity. Such counts must happen fast enough to guide decisions.
The team built an ELISA test for IgG and IgM antibodies. The test targets the binding region of the viral spike protein. They checked it against 200 blood donor samples as negative controls. None crossed the cutoff lines they set. Samples from other coronavirus infections showed little cross-reaction. The assays are suited to large population surveys. Public health teams gain a tool for tracking the pandemic's true reach.
Catalog record
| CREATOR | Perera RA, Mok CK, Tsang OT, Lv H, Ko RL, Wu NC, Yuan M, Leung WS, Chan JM, Chik TS, Choi CY, Leung K, Chan KH, Chan KC, Li KC, Wu JT, Wilson IA, Monto AS, Poon LL, Peiris M. |
|---|---|
| YEAR | 2020 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 31 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |